PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B

por Wu, Bin, Wang, Yan-xia, Wang, Jun-jie, Xiang, Dong-fang, Zhang, Meng-si, Yan, Ze-xuan, Wang, Wen-ying, Miao, Jing-ya, Lan, Xi, Liu, Jia-jia, Li, Zheng-yan, Li, Chuan, Fan, Jun-yan, Liu, Jun-yan, Jiang, Lei, Xu, Sen-lin, Cui, You-hong, Qian, Feng
Publicado 2022

Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria

por Xie, Xiao-Qing, Yang, Yi, Wang, Qiang, Liu, Hao-Fei, Fang, Xuan-Yu, Li, Cheng-Long, Jiang, Yi-Zhou, Wang, Shuai, Zhao, Hong-Yu, Miao, Jing-Ya, Ding, Shuai-Shuai, Liu, Xin-Dong, Yao, Xiao-Hong, Yang, Wen-Tao, Jiang, Jun, Shao, Zhi-Ming, Jin, Guoxiang, Bian, Xiu-Wu
Publicado 2023

EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma

por Gai, Qu-Jing, Fu, Zhen, He, Jiang, Mao, Min, Yao, Xiao-Xue, Qin, Yan, Lan, Xi, Zhang, Lin, Miao, Jing-Ya, Wang, Yan-Xia, Zhu, Jiang, Yang, Fei-Cheng, Lu, Hui-Min, Yan, Ze-Xuan, Chen, Fang-Lin, Shi, Yu, Ping, Yi-Fang, Cui, You-Hong, Zhang, Xia, Liu, Xindong, Yao, Xiao-Hong, Lv, Sheng-Qing, Bian, Xiu-Wu, Wang, Yan
Publicado 2022